Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS)
CNY 15.62
(0.64%)
CNY 15.62
(0.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 102.78 Million | 194.06 Million | 446.36 Million | 387.94 Million | 326.22 Million | 129.06 Million |
| Net Income | 139.78 Million | 248.99 Million | 445.85 Million | 341.82 Million | 176.9 Million | -22 Million |
| Depreciation & Amortization | 64.58 Million | 53.11 Million | 41.12 Million | 24.74 Million | 18.42 Million | 21.99 Million |
| Deferred income taxes | -23.9 Million | -14.4 Million | -4.11 Million | 20.23 Million | 23.25 Million | -49.32 Million |
| Stock-based compensation | 1.75 Million | 477.73 Thousand | 4.11 Million | -20.23 Million | 13.22 Million | - |
| Change in working capital | -82.03 Million | -74.22 Million | -41.46 Million | 28.48 Million | 116.57 Million | 102.13 Million |
| Other non-cash items | 219.47 Million | -19.89 Million | 841.86 Thousand | -7.11 Million | -22.16 Million | 26.93 Million |
| Investing Cash Flow | 198.49 Million | -181.03 Million | -1.87 Billion | -226.08 Million | -278.9 Million | -30.62 Million |
| Investments in PPE | -296.71 Million | -461.61 Million | -433.45 Million | -158.23 Million | -110 Million | -23.03 Million |
| Acquisitions | 1.03 Million | 0.99 | 1916.43 | - | 110 Million | 23.06 Million |
| Investment purchases | -3.62 Billion | -4.97 Billion | -5.74 Billion | -4.51 Billion | -744.22 Million | -38.74 Million |
| Sales/Maturities of investments | 4.12 Billion | 5.25 Billion | 4.3 Billion | 4.44 Billion | 575.33 Million | 31.13 Million |
| Other Investing Activities | 530.06 Million | -5 Million | 0.64 | -970.63 Thousand | -110 Million | -23.03 Million |
| Financing Cash Flow | 121.29 Million | -99.99 Million | 2.34 Billion | -49.29 Million | 165.83 Million | -57.32 Million |
| Debt repayment | -378.43 Million | -13.19 Million | -1 Million | -40 Million | -264.89 Million | -244.89 Million |
| Dividends payments | -99.5 Million | -89.37 Million | -690.27 Thousand | -1.87 Million | -14.14 Million | -48.85 Million |
| Common Stock Repurchased | - | - | 19.23 Million | - | - | - |
| Common Stock Issuance | - | - | -19.23 Million | - | - | - |
| Other Financing Activities | -150.61 Million | 3.36 Million | 2.34 Billion | -7.41 Million | 444.86 Million | 236.42 Million |
| Accounts receivables | -23.93 Million | -41.6 Million | -23.85 Million | -12.89 Million | -34.18 Million | 14.36 Million |
| Accounts payables | -72.56 Million | -27.15 Million | 73.54 Million | 69.87 Million | 152.17 Million | 147.35 Million |
| Inventory | 10.55 Million | 8.95 Million | -87.03 Million | -48.71 Million | -24.67 Million | -10.26 Million |
| Other working capital | 3.9 Million | -14.4 Million | -4.11 Million | 20.23 Million | 23.25 Million | 112.39 Million |
| Cash at beginning of period | 1.2 Billion | 1.29 Billion | 371.52 Million | 259.14 Million | 45.71 Million | 4.62 Million |
| Cash at end of period | 1.78 Billion | 1.2 Billion | 1.29 Billion | 371.52 Million | 259.14 Million | 45.71 Million |
| Capital Expenditure | -296.71 Million | -461.61 Million | -433.45 Million | -158.23 Million | -110 Million | -23.03 Million |
| Effect of forex changes on cash | 1.64 Million | -160.95 Thousand | -42.02 Thousand | -190.87 Thousand | 275.6 Thousand | -17.19 Thousand |
| Net cash flow / Change in cash | 576.63 Million | -87.12 Million | 921.44 Million | 112.37 Million | 213.42 Million | 41.09 Million |
| Free Cash Flow | -193.93 Million | -267.55 Million | 12.9 Million | 229.7 Million | 216.21 Million | 106.02 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 162.13 Million | 18.77 Million | 46.43 Million | 50.84 Million | 139.78 Million | 20.23 Million |
| Depreciation & Amortization | - | 18.78 Million | 18.78 Million | 16.6 Million | 64.58 Million | -31.07 Million |
| Deferred income taxes | - | - | - | - | -23.9 Million | - |
| Stock-based compensation | - | 2.45 Million | - | 1.75 Million | 1.75 Million | - |
| Change in working capital | - | -14.15 Million | - | -9.47 Million | -82.03 Million | 53.69 Million |
| Other non-cash items | -33.56 Million | 35.05 Million | -30.64 Million | 27.6 Million | 219.47 Million | -84.06 Million |
| Investing Cash Flow | -49.81 Million | 144.65 Million | 37.22 Million | -92.73 Million | 198.49 Million | 4.89 Million |
| Investments in PPE | -26.66 Million | -23.46 Million | -60.66 Million | -51.5 Million | -296.71 Million | -61.9 Million |
| Acquisitions | 80 Thousand | 5800.00 | - | 1.03 Million | 1.03 Million | 0.47 |
| Investment purchases | -280 Million | -352.93 Million | -320.1 Million | -1.12 Billion | -3.62 Billion | -535 Million |
| Sales/Maturities of investments | 256.77 Million | 521.04 Million | 418 Million | 1.08 Billion | 4.12 Billion | 601.79 Million |
| Other Investing Activities | 80 Thousand | 5800.00 | 100.24 Million | -26.76 Million | 530.06 Million | 66.79 Million |
| Financing Cash Flow | 6.24 Million | -105.02 Million | 131.88 Million | -115.14 Million | 121.29 Million | 266.58 Million |
| Debt repayment | -9.56 Million | -22 Million | -165.5 Million | -41.93 Million | -378.43 Million | -267 Million |
| Dividends payments | -2.72 Million | -89.79 Million | -2.39 Million | -99.5 Million | -99.5 Million | -99.5 Million |
| Common Stock Repurchased | - | - | - | -1 Million | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -593.78 Thousand | 6.77 Million | -33.61 Million | -50.55 Million | -150.61 Million | 533.99 Million |
| Accounts receivables | - | -5.56 Million | - | -23.93 Million | -23.93 Million | 69.83 Million |
| Accounts payables | - | - | - | - | -72.56 Million | - |
| Inventory | - | -8.59 Million | - | 10.55 Million | 10.55 Million | -16.13 Million |
| Other working capital | - | - | - | 3.9 Million | 3.9 Million | - |
| Cash at beginning of period | 1.88 Billion | 1.81 Billion | 1.78 Billion | 1.77 Billion | 1.2 Billion | 1.55 Billion |
| Cash at end of period | 1.95 Billion | 1.88 Billion | 1.96 Billion | 1.78 Billion | 1.78 Billion | 1.77 Billion |
| Capital Expenditure | -26.66 Million | -23.46 Million | -60.66 Million | -51.5 Million | -296.71 Million | -61.9 Million |
| Effect of forex changes on cash | - | - | - | 1.64 Million | 1.64 Million | -6.79 Million |
| Net cash flow / Change in cash | 78.22 Million | 66.63 Million | 184.9 Million | 8.01 Million | 576.63 Million | 223.47 Million |
| Free Cash Flow | 101.9 Million | 11.58 Million | -44.87 Million | 10.33 Million | -193.93 Million | -103.11 Million |
DCRU
VESTF
GLM
NFEI
GWAY
DHBUF